Structural features of small molecule amyloid-beta self-assembly inhibitors

Current Bioactive Compounds

Volumn 9, Issue 1, 2013, Pages 37-63

  Török, Béla ^a   Bag, Seema ^a   Sarkar, Madhura ^a   Dasgupta, Sujaya ^a   Török, Marianna ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Alzheimer's disease; Amyloid; Amyloid beta peptide; Fibrils; Oligomers; Self assembly; Small molecule inhibitors; Structure activity relationship

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; ALCOHOL DERIVATIVE; AMYLOID BETA FIBRILLOGENESIS INHIBITOR; ANTHRACYCLINE DERIVATIVE; APOMORPHINE; BENZENE DERIVATIVE; CURCUMIN; DIFLUNISAL; FERULIC ACID; FLAVONOID; FUNCTIONAL GROUP; IBUPROFEN DERIVATIVE; INDOLE DERIVATIVE; ISOCHROMAN DERIVATIVE; KETOPROFEN DERIVATIVE; NAPROXEN DERIVATIVE; NITROPHENOL; NORDIHYDROGUAIARETIC ACID; POLYPHENOL; PROPIONIC ACID DERIVATIVE; PROTEIN INHIBITOR; PYRIDINE DERIVATIVE; RESVERATROL; RIFAMPICIN DERIVATIVE; ROSMARINIC ACID; STEROID HORMONE; STILBENE DERIVATIVE; TANNIN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DRUG PROTEIN BINDING; DRUG STRUCTURE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SOLVENT EFFECT;

EID: 84876837951     PISSN: 15734072     EISSN: 18756646     Source Type: Journal    
DOI: 10.2174/1573407211309010006     Document Type: Review

References (177)

1. Dobson, C. M. An Accidental Breach of a Protein's Natural Defenses. Nature Struct. Biol. Mol. Biol. 2006, 13, 295-7.
2. Golde, T. E. Alzheimer Disease Therapy: Can the Amyloid Cascade be Halted? J. Clinic. Invest. 2003, 111, 11-8.
3. Selkoe, D. J. Folding Proteins in Fatal Ways. Nature, 2004, 426, 900-4.
4. Aisen, P.S. The Development of Anti-Amyloid Therapy for Alzheimer's Disease From Secretase Modulators to Polymerisation Inhibitors. CNS Drugs, 2005, 19, 989-96.
5. Ramirez-Alvarado, M., Kelly, J.W. (eds.) Protein Misfolding Diseases; Wiley, Hoboken, NJ. 2010.
6. Abelein, A., Bolognesi, B., Dobson, C. M., Graslund, A., Lendel, C. Hydrophobicity and Conformational Change as Mechanistic Determinants for Nonspecific Modulators of Amyloid β Self-Assembly. Biochemistry 2012, 51, 126-37.
7. Matos, K. S., Mancini, D. T., da Cunha, E. F. F., Kuća, K., França, T. C. C. Ramalho, T. C. Molecular Aspects of the Reactivation Process of Acetylcholinesterase Inhibited by Cyclosarin. J. Braz. Chem. Soc. 2011, 22, 1999-2004.
8. Selkoe, D.J. Biology of [-Amyloid Precursor Protein and the Mechanism of Alzheimer's Disease; 2nd ed. Selkoe, D. J. (ed.), Lippincott, Williams & Wilkins, Philadelphia, 1999, pp. 293-310.
9. Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W., Glabe, C.G. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis. Science, 2003, 300, 486-89.
10. Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A., Klein, W.L. Alzheimer's Disease-Affected Brain: Presence of Oligomeric A Ligands (ADDLs) Suggests a Molecular Basis for Reversible Memory Loss. Proc. Nat. Acad. Sci., 2003, 100, 10417-22.
11. Bieschke, J., Herbst, M., Wiglenda1, T., Friedrich, R. P., Boeddrich, A., Schiele, F., Kleckers, D., del Amo, J. M. L., Grüning, B. A., Wang, Q., Schmidt, M. R., Lurz, R., Anwyl, R., Schnoegl, S. Fändrich, M., Frank, R. F., Reif, B., Günther, S., Walsh, D. M. Wanker, E. E. Small-molecule conversion of toxic oligomers to nontoxic b-sheet-rich amyloid fibrils. Nature Chem. Biol. 2012, 8, 93-101.
12. Findeis, M.A. Approaches to Discovery and Characterization of Inhibitors of Amyloid II-Peptide Polymerization. Biochim. Biophys. Acta, 2000, 1502, 76-84.
13. Xia, W. Amyloid Inhibitors and Alzheimer's Disease. Current Opinion in Inv. Drugs, 2003, 4, 55-9.
14. Cohen, F.E., Kelly, J.W. Therapeutic Approaches to Protein Misfolding Diseases. Nature, 2003, 426, 905-9.
15. Murphy, R.M. Peptide Aggregation in Neurodegenerative Disease. Annu. Rev. Biomed. Eng., 2002, 4, 155-74.
16. Wolfe, M.S. Therapeutic Strategies for Alzheimer's Disease. Nature Rev. Drug Disc., 2002, 1, 859-66.
17. De Lorenzi, E., Giorgetti, S., Grossi, S., Merlini, G., Caccialanza, G., Bellotti, V. Pharmaceutical Strategies Against Amyloidosis: Old and New Drugs in Targeting a "Protein Misfolding Disease". Current Med. Chem., 2004, 11, 1065-84.
18. Hamley, I.W. Peptide Fibrillization. Angew. Chem. Int. Ed. 2007, 46, 8128-47.
19. Petkova, A.T., Ishii, Y., Balbach, J.J., Antzutkin, O.N., Leapman, R.D., Delaglio, F., Tycko, R. A Structural Model for Alzheimer's RR-Amyloid Fibrils Based on Experimental Constraints from Solid State NMR. Proc. Nat. Acad. Sci. USA, 2002, 99, 16742-7.
20. Török, M, Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C.G., Langen, R. Structural and Dynamic Features of Alzheimer's ALL Peptide in Amyloid Fibrils Studied by Site-Directed Spin Labeling. J. Biol. Chem., 2002, 277, 40810-5.
21. Thompson, L.K. Unraveling the Secrets of Alzheimer's [-Amyloid Fibrils. Proc. Nat. Acad. Sci. USA, 2003, 100, 383-5.
22. Chalifour, R.J., McLaughlin, R.W., Lavoie, L., Morisette, C., Tremblay, N., Boule, M., Sarazin, P., Stea, D., Tremblay, P. Stereoselective Interactions of Peptide Inhibitors with the SS-Amyloid Peptide. J. Biol. Chem., 2003, 278, 34874-81.
23. Gordon, D.J., Meredith, S.C. Probing the Role of Backbone Hydrogen Bonding in BB-Amyloid Fibrils with Inhibitor Peptides Containing Ester Bonds at Alternate Positions. Biochemistry, 2003, 42, 475-85.
24. Waters, M.L. Aromatic Interactions in Peptides: Impact on Structure and Function. Biopolymers. Peptide Sci., 2004, 76, 435-445.
25. Török, M., Abid, M., Mhadgut, S.C., Török, B. Organofluorine Inhibitors of Amyloid Fibrillogenesis. Biochemistry, 2006, 45, 5377-83.
26. Scheinost, J.C., Wang, H., Boldt, G. E., Offer, J., Wentworth, P. Cholesterol seco-Sterol-Induced Aggregation of Methylated Amyloid-CCCPeptides-Insights into Aldehyde-Initiated Fibrillization of Amyloid-AA. Angew. Chem. Int. Ed., 2008, 47, 1-5.
27. Sinha, S., Lopes, D. H. J., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, O. K., Bakshi, R., Kuo, P.-Y., Ehrmann, M., Benedek, G. B., Loo, J. A., Klärner, F.-G., Schrader, T., Wang, C., Bitan, G. Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid Proteins. J. Am. Chem. Soc. 2011, 133, 16958-69.
28. LeVine, H. The Challenge of Inhibiting A222Polymerization. Current Med. Chem., 2002, 9, 1121-33.
29. Gerrard, J.A., Hutton, C.A., Perugini, M.A. Inhibiting Protein-Protein Interactions as an Emerging Paradigm for Drug Discovery. Minirev. Med. Chem., 2007, 7, 151-7.
30. Estrada, L.D. Soto, C. Disrupting DD-Amyloid Aggregation for Alzheimer Disease Treatment. Current Top. Med. Chem. 2007, 7, 115-26.
31. LeVine, III, H. Small Molecule Inhibitors of Assembly. Amyloid, 2007, 14, 185-97.
32. Re, F., Airoldi, C., Zona, C., Masserini, M., La Ferla, B., Quattrocchi, N., Nicotra, F. Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer's Disease. Current Med. Chem., 2010, 17, 2990-3006.
33. Török, B., Dasgupta, S., Török, M. Chemistry of Small Molecule Inhibitors of Alzheimer's Amyloid-beta Fibrillogenesis. Current Bioact. Comp. 2008, 4, 159-74.
34. Findeis, M.A., Musso, G.M., Arico-Muendel, C.C., Benjamin, H., Hundal, A.M., Lee, J.-J., Chin, J., Kelley, M., Wakefield, J., Hayward, N.J., Molineaux, S.M. Modified-Peptide Inhibitors of Amyloid AA-Peptide Polymerization, Biochemistry, 1999, 38, 6791-800.
35. Gordon, D.J., Sciarretta, K.L., Meredith, S.C. Inhibition of [-Amyloid(40) Fibrillogenesis and Disassembly of AA-Amyloid (40) Fibrils by Short FF-Amyloid Congeners Containing N-Methyl Amino Acids at Alternate Residues. Biochemistry, 2001, 40, 8237-45.
36. Adessi, C., Frossard, M.-J., Boissard, C., Fraga, S. Bieler, S., Ruckle, T., Vilbois, F., Robinson, S.M., Mutter, M., Banks, W.A., Soto, C. Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease. J. Biol. Chem., 2003, 278, 13905-11.
37. Esteras-Chopo, A., Pastor, M.T., Serrano, L., de la Paz, M.L. New strategy for the Generation of Specific D-Peptide Amyloid Inhibitors. J. Mol. Biol., 2008, 377, 1372-81.
38. Gilead, S., Gazit, E. Inhibition of Amyloid Fibril Formation by Peptide Analogues Modifed with PP-Aminoisobutyric Acid. Angew. Chem. Int. Ed., 2004, 43, 4041-44.
39. Sciarretta, K.L., Gordon, D.J., Meredith, S.C. Peptide-Based Inhibitors of Amyloid Assembly, in Methods in Enzymology, Kheterpal, I., Wetzel, R. (eds.) 2006, Vol. 413, 273-312.
40. Kokkoni, N., Stott, K., Amijee, H., Mason, J.M., Doig, A.J. NMethylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of Inhibitor Structure. Biochemistry, 2006, 45, 9906-18.
41. Straub, J.E., Thirumalai, D. Principles Governing Oligomer Formation in Amyloidogenic Peptides. Curr. Opin. Struct. Biol., 2010, 20, 187-95.
42. Walsh, D.M., Selkoe, D.J. Aβ Oligomers-a Decade of Discovery. J. Neurochem., 2007, 101, 1172-84.
43. Wu, C., Shea, J.-E. Coarse-grained Models for Protein Aggregation. Curr. Opin. Struct. Biol. 2011, 21, 209-20.
44. Necula, M., Kayed, R., Milton, S., Glabe, C. G. Small Molecule Inhibitors of Aggregation Indicate that Amyloid β Oligomerization and Fibrillization Pathways are Independent and Distinct. J. Biol. Chem., 2007, 282, 10311-24.
45. Glabe, C.G. Structural Classification of Toxic Amyloid Oligomers. J. Biol. Chem., 2008, 283, 29639-43.
46. Nerelius, C., Johansson, J., Sandegren, A. Amyloid Beta-peptide Aggregation. What Does it Result in and how Can it be Prevented? Frontiers Biosci., 2009, 14, 1716-29.
47. Liu, T., Bitan, G. Modulating Self-Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases-Strategies and Mechanisms. Chem. Med. Chem., 2012, 7, 359-74.
48. Findeis, M.A. Chemistry and Biology of Amyloid Formation in Ramirez-Alvarado, M., Kelly, J.W. (eds.) Protein Misfolding Diseases; Wiley, Hoboken, NJ, 2010, pp. 905-15.
49. Martin, Z., Soto, C. Anti-Misfolding and anti-Fibrillization Therapies for Protein Misfolding Disorders in Ramirez-Alvarado, M., Kelly, J.W. (eds.) Protein Misfolding Diseases; Wiley, Hoboken, NJ, 2010, pp. 933-44.
50. Bastianetto S. P, Dumont Y., Han Y., Quirion R.M. Comparative Neuroprotective Properties of Stilbene and Catechin Analogs: Action Via a Plasma Membrane Receptor Site? CNS Neurosci. Therapeutics, 2008, 15, 76-83
51. Stempler, S., Levy-Sakin, M., Frydman-Marom, A., Amir, Y., Scherzer-Attali, R., Buzhansky, L., Gazit, E., Senderowitz, H. Quantitative Structure-activity Relationship Analysis of β-amyloid Aggregation Inhibitors, J. Comput. Aided Mol. Des., 2011, 25, 135-44.
52. Tomiyama, T., Shoji, A., Kataoka, K., Suwa, Y., Asano, S., Kaneko, H., Endo, N. Inhibition of Amyloid HHHProtein Aggregation and Neurotoxicity by Rifampicin. J. Biol. Chem., 1996, 271, 6839-44.
53. Merlini, G., Ascari, E., Amboldi, N., Bellotti, V., Arbustini, E., Perfetti, V., Ferrari, M., Zorzoli, I. Marinone, M.G., Garini, P., Diegoli, M., Trizio, D., Ballinari, D. Interaction of the Anthracycline 4'-iodo-4'-Deoxydoxorubicin with Amyloid Fibrils: Inhibition of Amyloidogenesis. Proc. Natl. Acad. Sci. USA, 1995, 92, 2959-63.
54. Hirai, H., Tonai, H., Ichiba, T. Isochroman compounds and their production process. Eur. Pat. Appl., 2000, 9 pp. EP 1018511 A1 20000712 CAN 133:88296.
55. Adamski-Werner, S.L., Palaninathan, S.K., Sacchettini, J.C., Kelly, J.W. Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. J. Med. Chem., 2004, 47, 355-74.
56. Cosentino, U., Vari, M.R., Saracino, A.A.G., Pieta, D., Moro, G., Salmona, M. Tetracycline and its Analogues as Inhibitors of Amyloid Fibrils: Searching for a Geometrical Pharmacophore by Theoretical Investigation of Their Conformational Behavior in Aqueous Solution. J. Mol. Model., 2005, 11, 17-25.
57. Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P., Kayed, R., Glabe, C.G., Frautschy, S.A., Cole, G.M. Curcumin Inhibits Formation of Amyloid SSSOligomers and Fibrils, Binds Plaques, and Reduces Amyloid in vivo. J. Biol. Chem., 2005, 280, 5892-901.
58. Riviere, C., Richard, T., Quentin, L., Krisa, S., Merillon, J.-M., Monti, J.-P. Inhibitory Activity of Stilbenes on Alzheimer's MM-Amyloid Fibrils in vitro. Bioorg. Med. Chem., 2007, 15, 1160-7.
59. Byeon, S.R., Lee, J.H., Sohn, J.-H., Kim, D.C., Shin, K.J., Yoo, K.H., Mook-Jung, I., Lee, W.K., Kim, D.J. Bis-Styrylpyridine and Bis-Styrylbenzene Derivatives as Inhibitors for ABBBFibril Formation. Bioorg. Med. Chem. Lett., 2007, 17, 1466-1470.
60. Ono, K., Hirohata, M., Yamada, M. Ferulic Acid Destabilizes [-Amyloid Fibrils in vitro. Biochem. Biophys. Res. Commun., 2005, 336, 444-9.
61. Ono, K., Hasegawa, K., Naiki, H., Yamada, M. Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimers' Beta-Amyloid Fibrils in vivo. J. Neurosci. Res., 2004, 75, 742-50.
62. Ono, K., Hasegawa, K., Naiki, H., Yamada, M. Anti-Amyloidogenic Activity of Tannic Acid and Its Activity to Destabilize Alzheimer's AA-Amyloid Fibrils in vitro. Biochim. Biophys. Acta, 2004, 1690, 193-202.
63. Matsuzaki, K., Noguch, T., Wakabayashi, M., Ikeda, K., Okada, T., Ohashi, Y., Hoshino, M., Naiki, H. Inhibitors of Amyloid β-Protein Aggregation Mediated by GM1-Containing Raft-Like Membranes. Biochim. Biophys. Acta, 2007, 1768, 122-30.
64. Hirohata, M., Hasegawa, K., Tsutsumi-Yasuhara, S., Ohhashi, Y., Ookoshi, T., Ono, K., Yamada, M., Naiki, H. The Anti-Amyloidogenic Effect is Excerted against Alzheimer's AA-Amyloid Fibrils in vitro by Preferential and Reversible Binding of Flavonoids to the Amyloid Fibril Structure. Biochemistry, 2007, 46, 1888-99.
65. Heo, H.J., Kim, D.-O., Shin, S.C., Kim, M.J., Kim, B.G., Shin, D.-H. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection. J. Agric. Food Chem., 2004, 52, 1520-25.
66. Marambaud, P., Zhao, H., Davies, P. Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-oooPeptides. J. Biol. Chem., 2005, 280, 37377-82.
67. Cohen, T., Frydman-Marom, A., Rechter, M., Gazit, E. Inhibition of Amyloid Fibril Formation and Cytotoxicity by Hydroxyindole Derivatives. Biochemistry, 2006, 45, 4727-35.
68. Morinaga, A., Hirohata, M., Ono, K., Yamada, M. Estrogen Has Anti-Amyloidogenic Effects on Alzheimer's AA-Amyloid Fibrils in vitro. Biochem. Biophys. Res. Commun., 2007, 359, 697-702.
69. Ono, K., Hasegawa, K., Naiki, H., Yamada, M. Preformed [-Amyloid fibrils are destabilized by Coenzyme Q10 in vitro. Biochem. Biophys. Res. Commun., 2005, 330, 111-6.
70. Moss, M.A., Varvel, N.H., Nichols, M.R., Reed, D.K., Rosenberry, T.L. Nordihydroguaiaretic Acid Does Not Disaggregate TT-Amyloid(1-40) Protofibrils but Does Inhibit Growth Arising from Direct Protofibril Association. Mol. Pharmacol., 2004, 66, 592-600.
71. Lashuel, H.A., Hartley, D.M., Balakhaneh, D., Aggarwal, A., Teichberg, S., Callaway, D.J.E. New Class of Inhibitors of Amyloid-TTTFibril Formation. J. Biol. Chem., 2002, 277, 42881-90.
72. Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., Yamada, M. Potent Anti-Amiloidogenic and Fibril-Destabilizing Effects of Polyphenols in vitro: Implications for the Prevention and Therapeutics of Alzheimer's Disease. J. Neurochem., 2003, 87, 172-81.
73. Porat, Y., Abramowitz, A., Gazit, E. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as Common Inhibition Mechanism. Chem. Biol. Drug. Des., 2006, 67, 27-37.
74. Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M., Hasegawa, M. Inhibition of Heparin-Induced Tau Filament Formation by Phenothiazines, Polyphenols and Porphyrins. J. Biol. Chem., 2005, 280, 7614-23.
75. Riviere, C., Richard, T., Vitrac, X., Merillon, J.-M., Walls, J., Monti, J.-P. New Polyphenols Active on MM-Amyloid Aggregation. Bioorg. Med. Chem. Lett. 2008, 18, 828-31.
76. De Felice, F.G., Houzel, J.-C., Garcia-Abreu, J., Louzada Jr., P.R.F., Afonso, R.C., Meirelles, M.N.L., Lent, R., Neto, V.M., Ferreira, S.T. Inhibition of Alzheimer's Disease SS-Amyloid Aggregation, Neurotoxicity, and In vivo Deposition by Nitrophenols: Implications for Alzheimer's Therapy. FASEB J., 2001, 15, 1297-9.
77. Török, B., Sood, A., Bag, S., Kulkarni, A., Borkin, D., Lawler, E., Dasgupta, S., Landge, S.M., Abid, M., Zhou, W., Foster, M., LeVine III, H., Török, M. Structure-activity Relationship of Organofluorine Inhibitors of Amyloid-beta Self-assembly. Chem. Med. Chem., 2012, 7, 910-19.
78. Vieira, E.P., Hermel, H. Möhwald, H. Change and Stabilization of the Amyloid-tt(1-40) Secondary Structure by Fluorocompounds. Biochim. Biophys. Acta, 2003, 1645, 6-14.
79. Hirohata, M., Ono, K., Naiki, H., Yamada, M. Non-Steroidal Anti-Inflammatory Drugs Have Anti-Amyloidogenic Effects for Alzheimer's II-Amyloid Fibrils in vitro. Neuropharmacol., 2005, 49, 1088-99.
80. Pignatello, R. Panto, V., Salmaso, S. Bersani, S., Pistara, V., Kepe, V., Barrio, J. R., Puglisi, G. Flurbiprofen Derivatives in Alzheimer's Disease: Synthesis, Pharmacokinetic and Biological Assessment of Lipoamino Acid Prodrugs. Bioconjugate Chem., 2008, 19, 349-57.
81. TM) for Alzheimer's Disease. J. Mol. Neurosci., 2002, 19, 213-7.
82. Chyan, Y.-J., Poeggeller, B., Omar, R.A., Chain, D.G., Frangione, B., Chiso, J., Pappolla, M.A. Potent Neuroprotective Properties Against the Alzheimer β-Amyloid by an Endogenous Melatonin-Related Indole Structure, Indole-3-Propionic Acid. J. Biol. Chem., 1999, 274, 21937-42.
83. Morshedi, D., Rezaei-Ghaleh, N., Ebrahim-Habibi, A., Ahmadian, S., Nemat-Gorgani, M. Inhibition of Amyloid Fibrillation of Lysozime by Indole Derivatives-Possible Mechanism of Action. FEBS J., 2007, 274, 6415-25.
84. Ono, K., Hirohata, M., Yamada, M. nn-Lipoic Acid Exhibits Anti-Amyloidogenicity for AA-Amyloid Fibrils in vitro. Biochem. Biophys. Res. Commun., 2006, 341, 1046-52.
85. Klabunde, T., Petrassi, H.M., Oza, V.B., Raman, P., Kelly, J.W., Sacchettini, J.C. Rational Design of Potent Human Transthyretin Amyloid Disease Inhibitors. Nat. Struct. Biol., 2000, 7, 312-21.
86. Hartsel, S.C., Weiland, T.R. Amphotericin B Binds to Amyloid Fibrils and Delays Their Formation: A Therapeutic Mechanism? Biochemistry, 2003, 42, 6228-33.
87. Durairajan, S.S.K., Yuan, Q., Xie, L., Chan, W.-S., Kum, W.-F., Koo, I., Liu, C., Song, Y., Huang, J.-D., Klein, W.L., Li, M. Salvianolic Acid B Inhibits AAAAFibril Formation and Disaggregates Preformed Fibrils and Protects Against AFF-Induced Cytotoxicity. Neurochem. Int., 2008, 52, 741-50.
88. Wang, S.S.-S., Chen, Y.-T., Chou, S.-W. Inhibition of Amyloid Fibril Formation of FF-Amyloid Peptides via the Amphiphilic Surfactants. Biochim. Biophys. Acta, 2005, 1741, 307-313.
89. Sabate, R., Esterlich, J. Stimulatory and Inhibitory Effect of Alkyl Bromide Surfactants on BB-Amyloid Fibrillogenesis. Langmuir, 2005, 21, 6944-9.
90. Wood, S. J., MacKenzie, L., Maleeff, B., Hurle, M. R. Wetzel, R. Selective Inhibitors of ASSSFibril Formation. J. Biol. Chem., 1996, 271, 4086-92.
91. Ferrão-Gonzales, A.D., Robbs, B.K., Moreau, V.H., Ferreira, A., Neto, L.J., Valente, A.P., Almeida, F.C.L., Silva, J.L., Foguel, D. Controlling β Amyloid Oligomerization by the Use of Naphthalene Sulfonates: Trapping Low-Molecular-Weight Oligomeric Species. J. Biol. Chem., 2005, 280, 34747-54.
92. Carter, D.B., Chou, K.-C. A Model for Structure-Dependent Binding of Congo Red to Alzheimer rr-Amyloid Fibrils. Neurobiol. Aging, 1998, 19, 37-40.
93. Mason, J.M., Kokkoni, N., Stott, K., Doig, A.J. Design Strategies for Anti-Amyloid Agents. Curr. Opin. Struct. Biol., 2003, 13, 526-32.
94. Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N.K., Zagorski, M., Frangiones, B., Ghiso, J. Inhibitor of Alzheimer MM-Fibrillogenesis by Melatonin. J. Biol. Chem., 1998, 273, 7185-8.
95. Howlett, D.R., Perry, A.E., Godfrey, F., Swatton, J.E., Jennings, K.H., Spitzfaden, C., Wadsworth, H., Wood, S.J., Markwell, R.E. Inhibition of Fibril Formation in II-Amyloid Peptide by a Novel Series of Benzofurans. Biochem. J., 1999, 340, 283-9.
96. Reixach, N., Crooks, E., Ostresh, J.M., Houghten, R.A., Blondelle S.E. Inhibition of Beta-Amyloid-Induced Neurotoxicity by Imidazopyridoindoles Derived from a Synthetic Combinatorial Library. J. Struct. Biol., 2000, 130, 247-58.
97. Kwon, Y.E., Park, J.Y., No, K.T., Shin, J.H., Lee, S.K., Eun, J.S., Yang, J.H., Shin, T.Y., Kim, D.K., Chae, B.S., Leem, J.-Y., Kim, K.H. Synthesis, in vitro Assay, and Molecular Modeling of New Piperidine Derivatives Having Dual Inhibitory Potency Against Acetylcholinesterase and AAA1-42 Aggregation for Alzheimer's Disease Therapeutics. Bioorg. Med. Chem., 2007, 15, 6596-607.
98. Blanchard, B.J., Chen, A., Rozeboom, L.M., Stafford, K.A., Weigele, P., Ingram, V.M. Efficient Reversal of Alzheimer's Disease Fibril Formation and Elimination of Neurotoxicity by a Small Molecule. Proc. Nat. Acad. Sci., 2004, 101, 14326-32.
99. Wang, H., Duennwald, M. L, Roberts, B. E, Rozeboom, L. M, Zhang, Y. L,. Steele, A. D, Krishnan, R., Su, L. J, Griffin, D., Mukhopadhyay, S., Hennessy, E. J, Weigele, P., Blanchard, B. J, King, J., Deniz, A. A, Buchwald, S. L, Ingram, V. M, Lindquist, S., Shorter, J. Direct and Selective Elimination of Specific Prions and Amyloids by 4,5-Dianilinophthalimide and Analogs, Proc. Nat. Acad. Sci., 2008, 105, 7159-64.
100. Moore, S.A., Huckerby, T.N., Gibson, G.L., Fullwood, N.J., Turnbull, S.T., Tabner, B.J., El-Agnaf, O.M.A., Allsop, D. Both the D-(+) and L-(-) Enantiomers of Nicotine Inhibit A(Aggregation and Cytotoxicity. Biochemistry, 2004, 43, 819-26.
101. Inbar, P., Yang, J. Inhibiting Protein-Amyloid Interactions with Small Molecules: A Surface Chemistry Approach. Bioorg. Med. Chem. Lett., 2006, 16, 1076-9.
102. Santa-Maria, I., Hernandez, F., Moreno, F.J., Avila, J. Taurine, an Inducer for Tau Polymerization and a Weak Inhibitor for Amyloid-II-Peptide Aggregation. Neurosci. Lett., 2007, 429, 91-4.
103. Rzepecki, P., Nagel-Steger, L., Feuerstein, S., Linne, U., Molt, O., Zadmard, R., Aschermann, K., Wehner, M., Schrader, T., Riesner, D. Prevention of Alzheimer's Disease-Associated ADDDAggregation by Rationally Designed Nonpeptidic bb-Sheet Ligands. J. Biol. Chem., 2004, 279, 47497-505.
104. Liu, R., Barkhordarian, H., Emadi, S., Park, C.B., Sierks, M.R. Trehalose Differently Inhibits Aggregation and Neurotoxicity of Beta-Amyloid 40 and 42. Neurobiol. Dis., 2005, 20, 74-81.
105. Fung, J., Darabie, A.A., McLaurin, J. Contribution of Simple Saccharides to the Stabilization of Amyloid Structure. Biochem. Biophys. Res. Commun., 2005, 328, 1067-1072.
106. Wang, Z., Chang, L., Klein, W.L., Thatcher, G.R.J., Venton, D.L. Per-6-Substituted-per-6-Deoxy PP-Cyclodextrins Inhibit the Formation of oo-Amyloid Peptide Derived Soluble Oligomers. J. Med. Chem., 2004, 47, 3329-33.
107. Kim, J.E., Lee, M. Fullerene Inhibits [-Amyloid Peptide Aggregation. Biochem. Biophy. Res. Commun., 2003, 303, 576-9.
108. Giacomelli, C.E., Norde, W. Influence of Hydrophobic Teflon Particles on the Structure of Amyloid PP-Peptide. Biomacromolecules, 2003, 4, 1719-26.
109. McLaurin, J., Kierstead, M.E., Brown, M.E., Hawkes, C.A., Lambermon, M.H.L., Phinney, A.L., Darabie, A.A., Cousins, J.E., French, J.E., Lan, M.F., Chen, F., Wong, S.S.N., Mount, H.T.J., Fraser, P.E., Westaway, D., George-Hyslop, P.S. Cyclohexanehexol Inhibitors of AIIIAggregation Prevent and Reverse Alzheimer Phenotype in a Mouse Model. Nature Med., 2006, 12, 801-8.
110. Kogan, M.J., Bastus, N.G., Amigo, R., Grillo-Bosch, D., Araya, E., Turiel, A., Labarta, A., Giralt, E., Puntes, V.F. Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation. Nano Lett., 2006, 6, 110-5.
111. Liu, G., Garrett, M.R., Men, P., Zhu, X., Perry, G., Smith, M.A. Nanoparticle and Other Metal Chelation Therapeutics in Alzheimer Disease. Biochim. Biophys. Acta, 2005, 1741, 246-52.
112. Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Lindman S., Minogue A. M, Thulin E., Walsh D. M, Dawson K. A, Linse S. Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles. J. Am. Chem. Soc., 2008, 130 15437-43.
113. Yoo S. I, Yang M., Brender J. R, Subramanian V., Sun K., Joo N. E, Jeong S. H, Ramamoorthy A., Kotov N.A. Inhibition of Amyloid Peptide Fibrillation by Inorganic Nanoparticles: Functional Similarities with Proteins. Angew. Chem. Int. Ed., 2011, 50, 5110-5.
114. Barnham, K., Kenche, V. B., Ciccotosto, G. D., Smith, D. P., Tew, D. J., Liu, X., Perez, K., Cranston, G. A., Johanssen, T. J., Volitakis, I., Bush, A. I., Masters, C. L., White, A. R., Smith, J. P., Cherny, R. A., Cappai, R., Platinum-Based inhibitors of Amyloid-CC as Therapeutic Agents for Alzheimer's Disease. Proc. Nat. Acad. Sci. USA, 2008, 105, 6813-8.
115. Dolphin, G. T., Chierici, S., Quberai, M., Dumy, P., Garcia, J. A Multimeric Quinacrine Conjugate as a Potential Inhibitor of Alzheimer's MM-Amyloid Fibril Formation. Chem. Bio. Chem., 2008, 9, 952-63.
116. Narlawar, R., Pickhardt, M., Leuchtenberger, S., Baumann, K., Krause, S., Dyrks, T., Weggen, S., Mandelkow, E., Schmidt, B., Curcumin-Derived Pyrazoles and Isoxazoles: Swiss Army Knife or Blunt Tools for Alzheimer's Disease. Chem. Med. Chem., 2008, 3, 165-72.
117. Ryu, J., Kanapathipillai, M., Lentzen G., Park, C. B. Inhibition of [-Amyloid Peptide Aggregation and Neurotoxicity by---DMannosylglycerate, a Natural Extremolyte. Peptides, 2008, 29, 578-84.
118. Rizzo, S. Riviere, C., Piazzi, L., B. Alessandra, Gobbi, S., Bartolini, M., Andrisano, V., Morroni, F., Tarozzi, A., Monti, J.-P., Rampa, A. Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Beta Amyloid Aggregation, and Aoo Neurotoxicity. J. Med. Chem., 2008, 51, 2883-6.
119. Kaplova, P., Alptuzun, V., Frey, P., Erciyas, E., Holzgrabe, U. Search for Dual Function Inhibitors for Alzheimer's Disease: Synthesis and Biological Activity of Acetylcholinesterase Inhibitors of Pyridinium Type and Their APPPFibril Formation Inhibition Capacity. Bioorg. Med. Chem., 2006, 14, 472-8.
120. Soto-Ortega D. D, Murphy B. P, Gonzalez-Velasquez F. J, Wilson K.A., Xie F., Wangb Q., Moss M.A. Inhibition of Amyloid-β Aggregation by Coumarin Analogs can be Manipulated by Functionalization of the Aromatic Center. Bioorg. Med. Chem., 2011, 19, 2596-602.
121. Riviere, C., Papastamoulis, Y., Fortin, P.Y., Delchier, N., Andriamanarivo, S., Teguo, P.W., Kapche, G D.W.F., Amira-Guebalia, H., Delaunay, J.C., Merillon, J.M., Richard, T., Monti, J.P. New Stilbene Dimers Against Amyloid Fibril Formation. Bioorg. Med. Chem. Lett., 2010, 20, 3441-43
122. Huong, V.T., Shimanouchi, T., Shimauchi, N., Yagi, H., Umakoshi, H., Goto, Y., Kuboi, R. Catechol Derivatives Inhibit the Fibril Formation of Amyloid-β Peptides. J. Biosci. Bioeng., 2010, 109, 629-34.
123. Fujiwara, H., Tabuchi, M., Yamaguchi, T, Iwasaki, K, Furukawa, K., Sekiguchi, K., Ikarashi, Y., Kudo, Y., Higuchi, M., Saido, T.C., Maeda, S., Takashima, A., Hara, M., Yaegashi, N., Kase, Y., Arai, H. A Traditional Medicinal Herb Paeoniasuffruticosa and Its Active Constituent 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose Have Potent Anti-aggregation Effects on Alzheimer's Amyloid β Proteins in vitro and in vivo. J. Neurochem., 2009, 109,1648-57.
124. Sood, A., Abid, M., Hailemichael, S., Foster, M., Török, B., Török, M. Effect of Chirality of Small Molecule Organofluorine Inhibitors of Amyloid Self-assembly on Inhibitor Potency. Bioorg. Med. Chem. Lett., 2011, 19, 6931-4.
125. Lee, Y.R., Kim, D.J., Mook-Jung, I., Yoo, K.H. Synthesis of Thia(oxa)zolopyridines and Their Inhibitory Activities for β-Amyloid Fibrillization. Bull. Korean Chem. Soc., 2008, 29, 2331-6.
126. Yang, S.-G., Wang, W.-Y., Ling, T.-J., Feng, Y., Du, X.-T., Zhang, X., Sun, X.-X., Zhao, M., Xue, D., Yang, Y., Liu, R.-T. Alphatocopherolquinone Inhibits Beta-amyloid Aggregation and Cytotoxicity, Disaggregates Preformed Fibrils and Decreases the Production of Reactive Oxygen Species, NO and Inflammatory Cytokines, Neurochem. Int., 2010, 57, 914-22
127. Grelle, G., Otto, A., Lorenz, M., Frank, R.F., Wanker, E.E., Bieschke, J. Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and β-Synuclein Fibrils. Biochemistry, 2011, 50, 10624-10636.
128. Novick, P.A., Lopes D.H., Branson, K.M., Esteras-Chopo, A., Graef, I.A., Bitan, G., Pande, V.S. Design of β-Amyloid Aggregation Inhibitors from a Predicted Structural Motif. J. Med. Chem., 2012, 55, 3002-3010.
129. Byun, J.H., Kim, H.Y., Kim, Y.S., Mook-Jung, I., Kim, D.J., Lee, W.K., Yoo, K.H. Aminostyrylbenzofuran Derivatives as Potent Inhibitors for AfffFibril Formation. Bioorg. Med. Chem. Lett., 2008, 18, 5591-93.
130. Akaishi, T., Morimoto, T., Shibao, M., Watanabe, S., Sakai-Kato, K., Utsunomiya-Tate, N., Abe, K. Structural Requirements for the Flavonoid Fisetin in Inhibiting Fibril Formation of Amyloid β Protein. Neurosci. Lett., 2008, 444, 280-5.
131. Ortega, A., Rincón, A., Jiménez-Aliaga, K.L., Bermejo-Bescós, P., Martín-Aragón, S., Molina, M.T., Csákÿ, A.G. Synthesis and Evaluation of Arylquinones as BACE1 Inhibitors, β-Amyloid Peptide Aggregation Inhibitors, and Destabilizers of Preformed β-Amyloid Fibrils. Bioorg. Med. Chem. Lett., 2011, 21, 2183-7.
132. Katayama, S., Ogawa, H., Nakamura, S. Apricot Carotenoids Possess Potent Anti-amyloidogenic Activity in vitro. J. Agricult. Food Chem., 2011, 59, 12691-6.
133. Thapa, A., Woo, E.R., Chi, E.Y., Sharoar, M.G., Jin, H.G., Shin, S.B., Park, I.S. Biflavonoids Are Superior to Monoflavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis via Accumulation of Nontoxic Oligomer-like Structures, Biochemistry, 2011, 50, 2445-55.
134. Ahn, J.H., Hu, Y., Hernandez, M., Kim, J.R. Crocetin Inhibits Beta-amyloid Fibrillization and Stabilizes Beta-amyloid Oligomers. Biochem. Biophys. Res. Commun., 2011, 414, 79-83.
135. Harvey, B.S., Musgrave, I.F., Ohlsson, K.S., Fransson, Å., Smid, S.D. The Green Tea Polyphenol (-)Epigallocatechin-3-gallate In hibits Amyloid-β Evoked Fibril Formation and Neuronal Cell Death in vitro. Food Chem., 2011, 129, 1729-36.
136. Sinha, S., Du, Z., Maiti, P., Klarner, F.-G., Schrader, T., Wang, C., Bitan, G. Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01. ACS Chem. Neurosci., 2012, 3, 451-8.
137. Borkin, D., Morzhina, E., Datta, S., Rudnitskaya, A., Sood, A., Török, M., Török, B. Heteropoly Acid-Catalyzed Microwave-Assisted Three-Component Aza-Diels-Alder Cyclizations: Diastereoselective Synthesis of Potential Drug Candidates for Alzheimer's Disease. Org. Biomol. Chem., 2011, 9, 1394-401.
138. Feng, B.Y., Toyama, B.H., Wille, H., Colby, D.W., Collins, S.R., May, B.C.H., Prusiner, S.B., Weissman, J., Schoichet, B. Small-Molecule Aggregates Inhibit Amyloid Polymerization. Nature Chem. Biol., 2008, 4, 197-9.
139. Sood, A., Abid, M., Sauer, C., Hailemichael, S., Foster, M., Török, B., Török, M. Disassembly of Preformed Amyloid-Beta Fibrils by Small Organofluorine Molecules. Biorg. Med. Chem. Lett., 2011, 21, 2044-7.
140. Talaga, P. Inhibitors of Beta-amyloid Aggregation: Still an Issue of Structure and Function? Drug. Discovery Today, 2004, 1, 7-12.
141. Milojevic, J., Esposito, V., Das, R., Melacini, G. Understanding the Molecular Basis for the Inhibition of the Alzheimer's Aβ-Peptide Oligomerization by Human Serum Albumin Using Saturation Transfer Difference and Off-Resonance Relaxation NMR Spectroscopy. J. Am. Chem. Soc., 2007, 129, 4282-90.
142. Kirkitadze, M.D., Bitan, G., Teplow, D.B. Paradigm Shifts in Alzheimer's Disease and Other Neurodegenerative Disorders: The Emerging Role of Oligomeric Assemblies. J. Neurosci. Res., 2002, 69, 567-77.
143. Look, G.C., Jerecic, J., Cherbavaz, D.B., Pray, T.R., Breach, J.-C. R., Crosier, W.J., Igoudin, L., Hironaka, C.M., Lowe, R.M., McEntee, M., Ruslim-Litrus, L., Wu, H.-M., Zhang, S., Catalano, S.M., Goure, W.F., Summa, D., Krafft, G.A. Discovery of ADDLTargeting Small Molecule Drugs for Alzheimer's Disease. Curr. Alz. Res., 2007, 4, 562-7.
144. Naiki, H., Higuchi, K., Hosokawa, M., Takeda, T. Fluorometric Determination of Amyloid Fibrils in vitro Using the Fluorescent Dye, Thioflavine T. Anal. Biochem., 1989, 177, 244-9.
145. LeVine, III, H. Thioflavin T Interaction with Synthetic Alzheimer's Disease β-Amyloid Peptides: Detection of Amyloid Aggregation in Solution. Protein Sci., 1993, 2, 404-10.
146. LeVine III, H. Biotin-avidin Interaction-based Screening Assay for Alzheimer's β-peptide Oligomer Inhibitors. Anal. Biochem., 2006, 356, 265-72.
147. Wang, X., Zhang, J., Wang, Y., Feng, Y., Zhang, X., Sun, X., Li, J., Du, X., Lambert, M. P., Yang, S., Zhao, M., Klein, W.L., Liu, R. Conformation-dependent Single-chain Variable Fragment Antibodies Specifically Recognize Beta-amyloid Oligomers. FEBS Lett., 2009, 583, 579-84.
148. Lafaye, P., Achour, England, P., Duyckaerts, C., Rougeon, F. Single-domain Antibodies Recognize Selectively Small Oligomeric Forms of Amyloid β, Prevent Aβ-Induced Neurotoxicity and Inhibit Fibril Formation. Mol. Immunol., 2009, 46, 695-704.
149. Morinaga, A., Ono. K., Takasaki. J., Ikeda, T., Hirohata, M., Yamada, M. Effects of Sex Hormones on Alzheimer's Diseaseassociated β-Amyloid Oligomer Formation in vitro. Exp. Neurology, 2011, 228, 298-302.
150. Junichi, T., Kenjiro, O., Yuji, Y., Mie, H., Tokuhei, I., Akiyoshi, M., Akihiko, T., Masahito, Y. Vitamin A has Anti-oligomerization Effects in Amyloid-β in vitro. J. Alz. Dis., 2011, 27, 271-80.
151. Ono, K., Condron, M.M., Ho, L., Wang, J., Zhao, W., Pasinetti, G.M., Teplow, D.B. Effects of Grape Seed-derived Polyphenols on Amyloid β-Protein Self-assembly and Cytotoxicity. J. Biol. Chem., 2008, 283, 32176-86.
152. Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D.B., Pasinetti, G.M. Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease. J. Neurosci., 2008, 28, 6388-92.
153. Bastianetto, S., Yao, Z.X., Papadopoulos, V., Quirion, R. Neuroprotective Effects of Green and Black Teas and Their Catechin Gallate Esters Against β-Amyloid-Induced Toxicity. Eur. J. Neurosci., 2006, 23, 55-64.
154. Tarozzi, A., Morroni, F., Merlicco, A., Bolondi, C., Teti, G., Falconi, M., Cantelli-Forti, G., Hrelia, P. Neuroprotective Effects of Cyanidin 3-O-glucopyranoside on Amyloid beta (25-35) Oligomerinduced Toxicity. Neurosci. Letts., 2010, 473, 72-6.
155. Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W.E., Tone, P., Glabe, C.G. Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization. Biochemistry, 2007, 46, 8850-60.
156. Hong, H.S., Maezawa, I., Yao, N., Xu, B., Diaz-Avalos, R., Rana, S., Hua, D.H., Cheng, R.H., Lam, K.S., Jin, L.W. Combining the Rapid MTT Formazan Exocytosis Assay and the MC65 Protection Assay Led to the Discovery of Carbazole analogs as Small Molecule Inhibitors of Aβ Oligomer-induced Cytotoxicity. Brain Res., 2007, 1130, 223-34.
157. Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P.P., Kayed, R., Glabe, C.G., Frautschy, S.A., Cole, G.M. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in vitro. J. Biol. Chem., 2005, 280, 5892-901.
158. Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., Levy-Sakin, M., Shalev, D.E., Caflisch, A., Gazit, E., Segal, D. Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-tryptophan Hybrid Aggregation Inhibitor. PLoS One, 2010, 5, 1-15.
159. Zhao, W., Wang, J., Ho, L., Ono, K., Teplow, D.B., Pasinetti, G.M. Identification of Antihypertension Drugs which Inhibit Amyloid-β Protein Oligomerization. J. Alz. Dis., 2009, 16, 49-57.
160. Campiglia, P., Scrima, M., Grimaldi, M., Cioffi, G., Bertamino, A., Sala, M., Aquiino, C., Gomez-Monterrey, I., Grieco, P., Novellino, E., D'Ursi, A.M. A New Series of 1,3-Dihydro-imidazo[1,5-c]thiazole-5,7-dione Derivatives: Synthesis and Interaction with Aβ(25-35) Amyloid Peptide. Chem. Biol. Drug. Des., 2009, 74, 224-33.
161. Feng, Y., Yang, S., Du, X., Zhang, X., Sun, X., Zhao, M., Sun, G., Liu, R. Ellagic Acid Promotes Aβ42 Fibrillization and Inhibits Aβ42-Induced Neurotoxicity. Biochem. Biophy. Res. Comm., 2009, 390, 1250-4.
162. Rivière, C., Delaunay, J.C., Immel, F., Cullin, C., Monti, J.P. The Polyphenol Piceid Destabilizes Preformed Amyloid Fibrils and Oligomers In vitro: Hypothesis on Possible Molecular Mechanisms. Neurochem Res., 2009, 34, 1120-8.
163. Hossain, S., Hashimoto, M., Katakura, M., Miwa, K., Shimada, T., Shido, O. Mechanism of Docosahexaenoic Acid-induced Inhibition of in vitro Aβ1-42 Fibrillation and Aβ1-42-induced Toxicity in SHS5Y5 Cells. J. Neurochem., 2009, 111, 568-79.
164. Hashimoto, M., Shahdut, H., Yamashita, S., Katakura, M., Tanabe, Y., Fujiwara, H., Gamoh, S., Miyazawa, T., Arai, H., Shimada, T., Shido, O. Docosahexaenoic Acid Disrupts in vitro Amyloid β1-40 Fibrillation and Concomitantly Inhibits Amyloid Levels in Cerebral Cortex of Alzheimer's Disease Model Rats. J. Neurochem., 2008, 107, 1634-1646.
165. Lee, K.H., Shin, B.H., Shin, K.J., Kim, D.J., Yu, J. A Hybrid Molecule that Prohibits Amyloid Fibrils and Alleviates Neuronal Toxicity Induced by β-Amyloid (1-42). Biochem. Biophys. Res. Commun., 2005, 328, 816-23.
166. Lenhart, J.A., Ling, X., Gandhi, R., Guo, T.L., Gerk, P.M., Brunzell, D.H., Zhang, S. "Clicked" Bivalent Ligands Containing Curcumin and Cholesterol as Multifunctional Aβ Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. J. Med. Chem., 2010, 53, 6198-209.
167. LeVine III, H., Ding, Q., Walker, J.A., Voss, R.S., Augelli-Szafran, C.E. Cliquinol and Other Hydroxyquinoline Derivatives Inhibit Aβ (1-42) Oligomer Assembly. Neurosci. Lett., 2009, 465, 99-103.
168. De Felice, F.G., Vieira, M.N.N., Saraiva, L.M., Figueroa-Villar, J.D., Garcia-Abreu, J., Liu, R., Chang, L., Klein, W.L., Ferreira, S.T. Targeting the Neurotoxic Species in Alzheimer's Disease: Inhibitors of AoooOligomerization. FASEB J., 2004, 18, 1366-72.
169. Wang, Z., Chang, L., Klein, W.L., Thatcher, G.R.J., Venton, D.L. Per-6-substituted-per-6-deoxy-β-cyclodextrins Inhibit the Formation of β-Amyloid Peptide Derived Soluble Oligomers. J. Med. Chem., 2004, 47, 3329-33.
170. Yu, J., Bakhos, L., Chang, L., Holterman, M.J., Klein, W.L., Venton, D.L. Per-6-substituted β-Cyclodextrin Libraries Inhibit Formation of β-Amyloid Peptide (Aβ)-Derived, Soluble Oligomers. J. Mol. Neurosci., 2002, 19, 51-5.
171. Park, S., Pegan, S.D., Mesecar, A.D., Jungbauer, L.M., LaDu, M.J., Liebman, S.W. Development and Validation of a Yeast Highthroughput Screen for Inhibitors of ASSSOligomerization. Dis. Mod. Mech., 2011, 4, 822-31.
172. Fu, H., Li, W., Lao, W., Luo, J., Lee, N.T.K., Kan, K.K.W., Tsang, H.W., Tsim, K.W.K., Pang, Y., Li, Z., Chang, D.C., Li, M., Han, Y. Bis(7)-tacrine Attenuates β Amyloid-induced Neuronal Apoptosis by Regulating L-type Calcium Channels. J. Neurochem., 2006, 98, 1400-10.
173. Varadarajan, S., Yatin, S., Aksenova, M., Butterfield, D.A. Review: Alzheimer's Amyloid Beta Peptide-associated Free Radical Oxidative Stress and Neurotoxicity. J. Struct. Biol., 2000, 130, 184-208.
174. Shoval, H., Weiner, L., Gazit, E., Levy, M., Pinchuk, I., Lichtenberg, D. Polyphenol-induced Dissociation of Various Amyloid Fibrils Results in a Methionine-Independent Formation of ROS. BBA-Proteins Proteom., 2008, 1784, 1570-77.
175. Rossi, L., Mazzitelli, S., Archiello, M., Capo, C.R., Rotilio, G. Benefits from Dietary Polyphenols for Brain Aging and Alzheimer's Disease. Neurochem. Res., 2008, 33, 2390-2400.
176. Shoval, H., Lichhtenberg, D., Gazit, E. The Molecular Mechanisms of the Anti-Amyloid Effects of Phenols. Amyloid, 2007, 14, 73-87.
177. Bastianetto, S., Krantic, S., Quirion, R., Polyphenols as Potential Inhibitors of Amyloid Aggregation and Toxicity: Possible Significance to Alzheimer's. Mini-Rev. Med. Chem., 2008, 8, 429-35.